A Combination of Anti-PD-L1 Treatment and Therapeutic Vaccination Facilitates Improved Retroviral Clearance via Reactivation of Highly Exhausted T Cells
Despite significant efforts, vaccines are not yet available for every infectious pathogen, and the search for a protective approach to prevent the establishment of chronic infections, i.e., with HIV, continues. Immune checkpoint therapies targeting inhibitory receptors, such as PD-1, have shown imp...
Guardado en:
Autores principales: | , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
American Society for Microbiology
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c4b0311ffd9843a69b3db45c416f2a05 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:c4b0311ffd9843a69b3db45c416f2a05 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:c4b0311ffd9843a69b3db45c416f2a052021-11-03T18:15:37ZA Combination of Anti-PD-L1 Treatment and Therapeutic Vaccination Facilitates Improved Retroviral Clearance via Reactivation of Highly Exhausted T Cells2161-21292150-751110.1128/mBio.02121-20https://doaj.org/article/c4b0311ffd9843a69b3db45c416f2a052021-02-01T00:00:00Zhttps://journals.asm.org/doi/10.1128/mBio.02121-20https://doaj.org/toc/2161-2129https://doaj.org/toc/2150-7511 Despite significant efforts, vaccines are not yet available for every infectious pathogen, and the search for a protective approach to prevent the establishment of chronic infections, i.e., with HIV, continues. Immune checkpoint therapies targeting inhibitory receptors, such as PD-1, have shown impressive results against solid tumors.Torben KnuschkeSebastian KollendaChristina WenzekGennadiy ZelinskyyPhiline SteinbachUlf DittmerJan BuerMatthias EppleAstrid M. WestendorfAmerican Society for MicrobiologyarticleMicrobiologyQR1-502ENmBio, Vol 12, Iss 1 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Microbiology QR1-502 |
spellingShingle |
Microbiology QR1-502 Torben Knuschke Sebastian Kollenda Christina Wenzek Gennadiy Zelinskyy Philine Steinbach Ulf Dittmer Jan Buer Matthias Epple Astrid M. Westendorf A Combination of Anti-PD-L1 Treatment and Therapeutic Vaccination Facilitates Improved Retroviral Clearance via Reactivation of Highly Exhausted T Cells |
description |
Despite significant efforts, vaccines are not yet available for every infectious pathogen, and the search for a protective approach to prevent the establishment of chronic infections, i.e., with HIV, continues. Immune checkpoint therapies targeting inhibitory receptors, such as PD-1, have shown impressive results against solid tumors. |
format |
article |
author |
Torben Knuschke Sebastian Kollenda Christina Wenzek Gennadiy Zelinskyy Philine Steinbach Ulf Dittmer Jan Buer Matthias Epple Astrid M. Westendorf |
author_facet |
Torben Knuschke Sebastian Kollenda Christina Wenzek Gennadiy Zelinskyy Philine Steinbach Ulf Dittmer Jan Buer Matthias Epple Astrid M. Westendorf |
author_sort |
Torben Knuschke |
title |
A Combination of Anti-PD-L1 Treatment and Therapeutic Vaccination Facilitates Improved Retroviral Clearance via Reactivation of Highly Exhausted T Cells |
title_short |
A Combination of Anti-PD-L1 Treatment and Therapeutic Vaccination Facilitates Improved Retroviral Clearance via Reactivation of Highly Exhausted T Cells |
title_full |
A Combination of Anti-PD-L1 Treatment and Therapeutic Vaccination Facilitates Improved Retroviral Clearance via Reactivation of Highly Exhausted T Cells |
title_fullStr |
A Combination of Anti-PD-L1 Treatment and Therapeutic Vaccination Facilitates Improved Retroviral Clearance via Reactivation of Highly Exhausted T Cells |
title_full_unstemmed |
A Combination of Anti-PD-L1 Treatment and Therapeutic Vaccination Facilitates Improved Retroviral Clearance via Reactivation of Highly Exhausted T Cells |
title_sort |
combination of anti-pd-l1 treatment and therapeutic vaccination facilitates improved retroviral clearance via reactivation of highly exhausted t cells |
publisher |
American Society for Microbiology |
publishDate |
2021 |
url |
https://doaj.org/article/c4b0311ffd9843a69b3db45c416f2a05 |
work_keys_str_mv |
AT torbenknuschke acombinationofantipdl1treatmentandtherapeuticvaccinationfacilitatesimprovedretroviralclearanceviareactivationofhighlyexhaustedtcells AT sebastiankollenda acombinationofantipdl1treatmentandtherapeuticvaccinationfacilitatesimprovedretroviralclearanceviareactivationofhighlyexhaustedtcells AT christinawenzek acombinationofantipdl1treatmentandtherapeuticvaccinationfacilitatesimprovedretroviralclearanceviareactivationofhighlyexhaustedtcells AT gennadiyzelinskyy acombinationofantipdl1treatmentandtherapeuticvaccinationfacilitatesimprovedretroviralclearanceviareactivationofhighlyexhaustedtcells AT philinesteinbach acombinationofantipdl1treatmentandtherapeuticvaccinationfacilitatesimprovedretroviralclearanceviareactivationofhighlyexhaustedtcells AT ulfdittmer acombinationofantipdl1treatmentandtherapeuticvaccinationfacilitatesimprovedretroviralclearanceviareactivationofhighlyexhaustedtcells AT janbuer acombinationofantipdl1treatmentandtherapeuticvaccinationfacilitatesimprovedretroviralclearanceviareactivationofhighlyexhaustedtcells AT matthiasepple acombinationofantipdl1treatmentandtherapeuticvaccinationfacilitatesimprovedretroviralclearanceviareactivationofhighlyexhaustedtcells AT astridmwestendorf acombinationofantipdl1treatmentandtherapeuticvaccinationfacilitatesimprovedretroviralclearanceviareactivationofhighlyexhaustedtcells AT torbenknuschke combinationofantipdl1treatmentandtherapeuticvaccinationfacilitatesimprovedretroviralclearanceviareactivationofhighlyexhaustedtcells AT sebastiankollenda combinationofantipdl1treatmentandtherapeuticvaccinationfacilitatesimprovedretroviralclearanceviareactivationofhighlyexhaustedtcells AT christinawenzek combinationofantipdl1treatmentandtherapeuticvaccinationfacilitatesimprovedretroviralclearanceviareactivationofhighlyexhaustedtcells AT gennadiyzelinskyy combinationofantipdl1treatmentandtherapeuticvaccinationfacilitatesimprovedretroviralclearanceviareactivationofhighlyexhaustedtcells AT philinesteinbach combinationofantipdl1treatmentandtherapeuticvaccinationfacilitatesimprovedretroviralclearanceviareactivationofhighlyexhaustedtcells AT ulfdittmer combinationofantipdl1treatmentandtherapeuticvaccinationfacilitatesimprovedretroviralclearanceviareactivationofhighlyexhaustedtcells AT janbuer combinationofantipdl1treatmentandtherapeuticvaccinationfacilitatesimprovedretroviralclearanceviareactivationofhighlyexhaustedtcells AT matthiasepple combinationofantipdl1treatmentandtherapeuticvaccinationfacilitatesimprovedretroviralclearanceviareactivationofhighlyexhaustedtcells AT astridmwestendorf combinationofantipdl1treatmentandtherapeuticvaccinationfacilitatesimprovedretroviralclearanceviareactivationofhighlyexhaustedtcells |
_version_ |
1718445482662952960 |